This review provides an overview of the current understanding, treatment, and management of arrhythmia-induced cardiomyopathy, with a focus on AF-mediated cardiomyopathy.
Synthesizes current management of AF-mediated cardiomyopathy; leaves open need for prospective trials to guide therapy.
Arrhythmia induced cardiomyopathies (AIC) refer to the collective condition of Arrhythmia, Tachycardia, and ectopy-induced Cardiomyopathy. Atrial fibrillation (AF) and heart failure (HF) are modern epidemics that often coexist and exacerbate one another. We aim to provide an overview of the current understanding and evidence for treatment and management in AIC with a particular focus on AF-mediated cardiomyopathy and suggest approaches to recognize, screen, and manage AIC.
No takes yet. Share an insight, caveat, or question.
Sugumar et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: